Assessing and Modulating Kynurenine Pathway Dynamics in Huntington's Disease: Focus on Kynurenine 3-Monooxygenase. (2018)
Attributed to:
CHARACTERISING KYNURENINE 3-MONOOXYGENASE (KMO) AS A THERAPEUTIC TARGET FOR HUNTINGTON'S DISEASE
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1007/978-1-4939-7825-0_18
PubMed Identifier: 29856028
Publication URI: http://europepmc.org/abstract/MED/29856028
Type: Journal Article/Review
Volume: 1780
Parent Publication: Methods in molecular biology (Clifton, N.J.)
ISSN: 1064-3745